Skip to Main content Skip to Navigation
Journal articles

Classification of current anticancer immunotherapies

Lorenzo Galluzzi 1, 2 Erika Vacchelli 1 José-Manuel Bravo-San Pedro 1 Aitziber Buqué 1 Laura Senovilla 1 Elisa Elena Baracco 3, 1 Norma Bloy 1, 3 Francesca Castoldi 1, 3, 4 Jean-Pierre Abastado 5 Patrizia Agostinis 6 Fernando Aranda 1, 7 Maha Ayyoub 8, 9 Philipp Beckhove 10 Jean-yves Blay 11 Laura Bracci 12 Anne Caignard 13 Chiara Castelli 14 Federica Cavallo 15 Estaban Celis 16 Vincenzo Cerundolo 17 Aled Clayton 18, 19, 20 Mario P Colombo 14 Lisa Coussens 21 Madhav V Dhodapkar 22 Alexander M Eggermont 23 Douglas T Fearon 24 Wolf H Fridman 25 Kitka Fučíková 4, 26 Dmitry I Gabrilovich 27 Jérôme Galon 25 Abhishek Garg 6 François Ghiringhelli 28 Giuseppe Giaccone 29, 30 Eli Gilboa 31 Sacha Gnjatic 31 Axel Hoos 32 Anne Hosmalin 33 Dirk Jäger 34 Pawel Kalinski 35, 36, 37 Klas Kärre 38 Oliver Kepp 36, 39 Rolf Kiessling 40 John J Kirkwood 41 Eva Klein 38 Alexander Knuth 36 Claire E Lewis 42 Roland Liblau 43 Michael T Lotze 36, 35 Enrico Lugli 44 Jean-Pierre Mach 45 Fabrizio Mattei 12 Domenico Mavilio 44, 46 Ignacio Melero 47, 48 Cornelis J Melief 49, 50 Elizabeth A Mittendorf 51 Lorenzo Moretta 52 Adekunke Odunsi 53 Hideho Okada 54 Anna Karolina Paluka 55 Marcus E Peter 56 Kenneth J Pienta 57 Angel Porgador 58 George C Prendergast 59 Gabriel A Rabinovich 60 Nicholas P Restifo 29 Naiyer Rizvi 61 Catherine Sautès-Fridman 25 Hans Schreiber 62 Barbara Seliger 63 Hiroshi Shiku 64 Bruno Silva-Santos 65 Mark J Smyth 66, 67 Daniel A Speiser 68, 69 Radek Spisek 4, 26 Pramod K Srivastava 70, 71 James E Talmadge 72 Eric Tartour 73, 74 Sjoerd H van Der Burg 75 Benoît J van den Eynde 76, 77, 78 Richard Vile 79 Hermann Wagner 80 Jeffrey S Weber 81 Theresa L Whiteside 35, 82 Jedd D Wolchok 83, 84 Laurence Zitvogel 85, 86 Weiping Zou 87 Guido Kroemer 1, 2, 88 
1 Equipe labellisée Ligue contre le cancer - CRC - Inserm U1138 - Apoptose, cancer et immunité
IGR - Institut Gustave Roussy, CRC - Centre de Recherche des Cordeliers
2 UPD5 - Université Paris Descartes - Paris 5
3 UP11 - Université Paris-Sud - Paris 11
4 Sotio a.c.
5 Pole d’innovation thérapeutique en oncologie
6 Cell Death Research and Therapy (CDRT) Laboratory
7 Group of Immune receptors of the Innate and Adaptive System
8 UNICANCER/ICO - Institut de Cancérologie de l'Ouest [Angers/Nantes]
9 Cancer Vaccines and Immune Regulation
10 Translational Immunology Division
11 UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon
12 Dept. of Hematology, Oncology and Molecular Medicine
13 A2T - Alloimmunité-Autoimmunité-Transplantation
14 Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine
15 Molecular Biotechnology Center, Dept. of Molecular Biotechnology and Health Sciences
16 Cancer Immunology, Inflammation and Tolerance Program
17 MRC Human Immunology Unit
18 Department of Oncology - Pathology
19 Institute of Cancer & Genetics
20 Velindre Cancer Centre
21 Knight Cancer Institute
22 Sect. of Hematology and Immunobiology,Yale Cancer Center
23 IGR - Institut Gustave Roussy
24 Cold Spring Harbor Laboratory, NY
25 CRC - Centre de Recherche des Cordeliers
26 Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol
27 Dept. of Pathology and Laboratory Medicine, Perelman School of Medicine
28 UNICANCER/CRLCC-CGFL - Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon]
29 NCI-NIH - National Cancer Institute [Bethesda]
30 Lombardi Comprehensive Cancer Center
31 Dept. of Microbiology and Immunology, Sylvester Comprehensive Cancer Center
32 Glaxo Smith Kline, Cancer Immunotherapy Consortium
33 IC UM3 (UMR 8104 / U1016) - Institut Cochin
34 National Center for Tumor Diseases
35 Hillman Cancer Center
36 Department of Surgery
37 Dept. of Immunology and Infectious Diseases and Microbiology
38 Dept. of Microbiology, Tumor and Cell Biology
39 Plateforme de métabolomique
Direction de la recherche [Gustave Roussy]
40 Dept. of Oncology
41 Cancer Institute Laboratory
42 Academic Unit of Inflammation and Tumour Targeting, Dept. of Oncology
43 CPTP - Centre de Physiopathologie Toulouse Purpan
44 Unit of Clinical and Experimental Immunology
45 Institut de Biochimie
46 Dept. of Medical Biotechnologies and Translational Medicine
47 Dept. of Immunology, Centro de Investigación Médica Aplicada (CIMA)
48 Dept. of Oncology
49 ISA Therapeutics
50 Dept. of Immunohematology and Blood Transfusion
51 Research Dept. of Surgical Oncology
52 Istituto Giannina Gaslini
53 Center for Immunotherapy [Buffalo]
54 Dept. of Neurological Surgery
55 JAX - The Jackson Laboratory [Bar Harbor]
56 Div. of Hematology/Oncology
57 The James Buchanan Brady Urological Institute
58 Shraga Segal Department of Microbiology and Immunology
59 Cell Biology and Signaling Program
60 Laboratorio de Inmunopatología
61 Memorial Sloane Kettering Cancer Center [New York]
62 Dept. of Pathology, The Cancer Research Center
63 Institute of Medical Immunology
64 Department of Immuno-gene Therapy
65 Instituto de Medicina Molecular
66 Immunology in Cancer and Infection Laboratory
67 School of Medicine
68 Dept. of Oncology
69 Ludwig Cancer Research Center
70 Dept. of Immunology
71 Carole and Ray Neag Comprehensive Cancer Center
72 Laboratory of Transplantation Immunology, Dept. of Pathology and Microbiology
73 PARCC - UMR-S U970 - Paris-Centre de Recherche Cardiovasculaire
74 Service d'immunologie biologique
75 Dept. of Clinical Oncology
76 UCL - Université Catholique de Louvain = Catholic University of Louvain
77 Ludwig Institute for Cancer Research
78 de Duve Institute
79 Dept. of Molecular Medicine and Immunology
80 Institute of Medical Microbiology, Immunology and Hygiene
81 Donald A. Adam Comprehensive Melanoma Research Center
82 University of Pittsburgh School of Medicine
83 Dept. of Medicine and Ludwig Center
84 Weill Medical College of Cornell University [New York]
85 CIC 1428 , CBT 507 - Centre d'Investigation Clinique en Biotherapie des cancers
86 UMR 1015 - Immunologie des tumeurs et immunothérapie
87 Medical School
88 Pôle de biologie
Abstract : NA
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-01142463
Contributor : Mireille Bos Connect in order to contact the contributor
Submitted on : Wednesday, April 15, 2015 - 11:46:36 AM
Last modification on : Saturday, June 25, 2022 - 9:09:29 PM

File

Vignette du document
2998-36904-3-PB.pdf
Publisher files allowed on an open archive

Identifiers

  • HAL Id : inserm-01142463, version 1
  • PUBMED : 25537519

Collections

INSERM | UNIV-PARIS5 | UNIV-PARIS7 | UNIV-NANTES | UPMC | EPHE | UNIV-TLSE3 | CNRS | UNIV-LYON1 | FNCLCC | CGFL | IGR | CURIE | ICO | CORDELIERS | PSL | CRCL | SORBONNE-UNIVERSITE | SU-SCIENCES | UDL | UNIV-PARIS | UP-SANTE | SU-TI | INFINITY | UNIV-UT3

Citation

Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, et al.. Classification of current anticancer immunotherapies. Oncotarget, Impact journals, 2014, pp.12472-508. ⟨inserm-01142463⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

742

Files downloads

547